Status:
UNKNOWN
Crossover Comparison of Tidal Volume Delivery During Nasal Intermittent Positive Pressure Ventilation in Preterm Infants: Infant Cannula vs. Nasal Continuous Positive Airway Pressure Prongs
Lead Sponsor:
Arkansas Children's Hospital Research Institute
Conditions:
Respiratory Distress Syndrome in Premature Infant
Eligibility:
All Genders
Up to 28 years
Phase:
NA
Brief Summary
Crossover bedside clinical study to examine relative tidal volume delivery during nasal intermittent positive pressure ventilation (NIPPV) and directly compare the RAM® infant cannula to a nasal conti...
Detailed Description
Bedside crossover study of neonates with mild respiratory distress receiving NIPPV. Infants serve as their own controls and are randomized to initial interface of either RAM® infant cannula or Miniflo...
Eligibility Criteria
Inclusion
- Chronologic age less than 28 days
- Gestational age at birth between 24 weeks 0 days to 34 weeks 6 days
- Currently receiving NIPPV, NIV NAVA, or nCPAP
Exclusion
- Oxygen requirement greater than 40%
- Peak inspiratory pressure greater than 20 cm H2O
- Major congenital anomalies of the heart or lungs
Key Trial Info
Start Date :
March 7 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 30 2020
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT04326270
Start Date
March 7 2019
End Date
June 30 2020
Last Update
March 30 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Arkansas Children's Hospital
Little Rock, Arkansas, United States, 72202